Shabaninejad, H. and Asgharzadeh, A. and Rezaei, N. and Rezapoor, A. (2016) A Comparative Study of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin in Adult Patients with Primary Immunodeficiency Diseases: A Systematic Review and Meta-Analysis. Expert Review of Clinical Immunology, 12 (5). pp. 595-602.
Full text not available from this repository.Abstract
Subcutaneous immunoglobulin (SCIG) is a new therapeutic procedure for patients with primary immunodeficiency (PI). This research is a systematic review of studies on the efficacy and safety of intravenous immunoglobulin (IVIG) and SCIG in adult patients with PI. This study includes a systematic review of cohorts and randomized clinical trials (24 articles) from 5 databases with no time limits. Random effects meta-analysis was performed for outcomes such as efficacy and safety. Standard mean difference (SMD) of serum immunoglobulin level was equal to 0.336 (P <0.01; 0.205-0.467) and the odds ratio (OR) of side effects was 0.497 (P=0.1; 0.180-1.371). The results indicate that SCIG leads to a higher level of immunoglobulin and a reduction in side effects but shows the same infection rate as IVIG. Our analysis shows that shifting from IVIG to SCIG therapy can have clinical benefits for PI patients. © 2016 Informa UK Limited.
| Item Type: | Article |
|---|---|
| Additional Information: | cited By 6 |
| Depositing User: | eprints admin |
| Date Deposited: | 04 Jul 2018 09:50 |
| Last Modified: | 04 Jul 2018 09:50 |
| URI: | http://eprints.iums.ac.ir/id/eprint/3653 |
Actions (login required)
 |
View Item |
